We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Ratna Patra, vice chairman of Square Pharmaceuticals, has announced plans to acquire 15 lakh shares of the company at the prevailing market price within the next 30 days. The announcement was made ...
Square Pharmaceuticals' Vice-Chairman Ratna Patra has announced plans to acquire 1.5 million shares of the company. This purchase is valued at approximately Tk33 crore at current market rates. Ratna, ...
Indian multinational pharma company Sun Pharmaceutical Industries on Monday announced a definitive agreement to acquire Nasdaq-listed immunotherapy and targeted oncology firm Checkpoint Therapeutics ...
Sun Pharmaceutical Industries Ltd has entered into an agreement to acquire US-based immunotherapy and targeted oncology company, Checkpoint Therapeutics Inc, a development that would bring the ...
Sun Pharma will acquire Checkpoint Therapeutics for $355 million, expected to close by Q2 2025. The deal strengthens Sun Pharma’s oncology portfolio with FDA-approved UNLOXCYT for advanced cutaneous ...
Sun Pharmaceutical Industries Limited on Monday announced that it will acquire Checkpoint, an immunotherapy and targeted oncology company. According to the company’s exchange filing, Checkpoint ...
Sun Pharma is going to acquire Checkpoint Therapeutics for an upfront cash payment of $4.10 per share, an official statement from the company revealed on Monday. The deal will come up to $355 million ...
After months of searching for a partner for its recently approved cancer drug, Checkpoint Therapeutics has instead secured a buyer.
"Our exports have grown due mainly to increasing orders from the US, Unicef and the World Health Organization," said Muhammad Zahangir Alam, chief financial officer at Square Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback